These 4 anti-obesity drug stocks could soar, Berenberg says
(*4*)The anti-obesity drug market is anticipated to stay in focus this yr after a bumper 2023 for weight reduction drugmakers ...
(*4*)The anti-obesity drug market is anticipated to stay in focus this yr after a bumper 2023 for weight reduction drugmakers ...
Novo Nordisk and Eli Lilly reign over the anti-obesity drug market, and don't expect this duopoly to end soon, analysts ...
Most analysts predict the market for latest weight reduction drugs similar to Wegovy and Mounjaro will probably be enormous, but ...
[mailpoet_form id=”1″]
© 2022. All Right Reserved By Moneyoutlook.com